Thomas G. Martin, MD The University of California San Francisco (UCSF) has a number of ongoing clinical trials in both the newly diagnosed and relapsed/refractory settings of multiple myeloma that are open for patient enrollment and, if positive, could dramatically change practice, explained Thomas...